Form 8-K - Current report:
SEC Accession No. 0001140361-25-004342
Filing Date
2025-02-13
Accepted
2025-02-13 16:37:12
Documents
17
Period of Report
2025-02-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20043283x2_8k.htm   iXBRL 8-K 54614
2 EXHIBIT 1.1 ny20043283x2_ex1-1.htm EX-1.1 207324
3 EXHIBIT 5.1 ny20043283x2_ex5-1.htm EX-5.1 81777
4 EXHIBIT 99.1 ny20043283x2_ex99-1.htm EX-99.1 7702
8 ny20043283x2_ex5-1img01.jpg GRAPHIC 60851
  Complete submission text file 0001140361-25-004342.txt   652994

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA atai-20250212.xsd EX-101.SCH 3973
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE atai-20250212_lab.xml EX-101.LAB 22690
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atai-20250212_pre.xml EX-101.PRE 16546
20 EXTRACTED XBRL INSTANCE DOCUMENT ny20043283x2_8k_htm.xml XML 4212
Mailing Address WALLSTRASSE 16 BERLIN 2M 10179
Business Address WALLSTRASSE 16 BERLIN 2M 10179 49 89 2153 9035
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40493 | Film No.: 25620942
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)